Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples?

Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. diffic...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical microbiology Vol. 63; no. 4; pp. 590 - 593
Main Authors Whitehead, Simon J., Shipman, Kate E., Cooper, Mike, Ford, Clare, Gama, Rousseau
Format Journal Article
LanguageEnglish
Published Reading Society for General Microbiology 01.04.2014
Subjects
Online AccessGet full text
ISSN0022-2615
1473-5644
1473-5644
DOI10.1099/jmm.0.067389-0

Cover

Abstract Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins ( n  = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation ( n  = 75). Non-parametric ANOVA (Kruskal–Wallis) was used for data analysis. C. difficile positive samples had higher ( P <0.05) median (interquartile range) f-Cp levels; 336 µg g −1 (208–536) for toxin and 249 µg g −1 (155–498) for GDH and toxin gene positive compared with 106 µg g −1 (46–176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g −1 ). A f-Cp concentration >50 µg g −1 was 96 % sensitive and 26 % specific for C. difficile , with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity.
AbstractList Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins ( n  = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation ( n  = 75). Non-parametric ANOVA (Kruskal–Wallis) was used for data analysis. C. difficile positive samples had higher ( P <0.05) median (interquartile range) f-Cp levels; 336 µg g −1 (208–536) for toxin and 249 µg g −1 (155–498) for GDH and toxin gene positive compared with 106 µg g −1 (46–176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g −1 ). A f-Cp concentration >50 µg g −1 was 96 % sensitive and 26 % specific for C. difficile , with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity.
Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins (n = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (n = 75). Non-parametric ANOVA (Kruskal-Wallis) was used for data analysis. C. difficile positive samples had higher (P<0.05) median (interquartile range) f-Cp levels; 336 µg g(-1) (208-536) for toxin and 249 µg g(-1) (155-498) for GDH and toxin gene positive compared with 106 µg g(-1) (46-176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g(-1)). A f-Cp concentration >50 µg g(-1) was 96 % sensitive and 26 % specific for C. difficile, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity.
Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins (n = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (n = 75). Non-parametric ANOVA (Kruskal-Wallis) was used for data analysis. C. difficile positive samples had higher (P<0.05) median (interquartile range) f-Cp levels; 336 µg g(-1) (208-536) for toxin and 249 µg g(-1) (155-498) for GDH and toxin gene positive compared with 106 µg g(-1) (46-176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g(-1)). A f-Cp concentration >50 µg g(-1) was 96 % sensitive and 26 % specific for C. difficile, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity.Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins (n = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (n = 75). Non-parametric ANOVA (Kruskal-Wallis) was used for data analysis. C. difficile positive samples had higher (P<0.05) median (interquartile range) f-Cp levels; 336 µg g(-1) (208-536) for toxin and 249 µg g(-1) (155-498) for GDH and toxin gene positive compared with 106 µg g(-1) (46-176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g(-1)). A f-Cp concentration >50 µg g(-1) was 96 % sensitive and 26 % specific for C. difficile, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity.
Author Ford, Clare
Shipman, Kate E.
Gama, Rousseau
Whitehead, Simon J.
Cooper, Mike
Author_xml – sequence: 1
  givenname: Simon J.
  surname: Whitehead
  fullname: Whitehead, Simon J.
  organization: Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK
– sequence: 2
  givenname: Kate E.
  surname: Shipman
  fullname: Shipman, Kate E.
  organization: Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK
– sequence: 3
  givenname: Mike
  surname: Cooper
  fullname: Cooper, Mike
  organization: Microbiology, New Cross Hospital, Wolverhampton, UK
– sequence: 4
  givenname: Clare
  surname: Ford
  fullname: Ford, Clare
  organization: Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK
– sequence: 5
  givenname: Rousseau
  surname: Gama
  fullname: Gama, Rousseau
  organization: Research Institute, Healthcare Sciences, Wolverhampton University, Wolverhampton, UK, Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28392015$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24464697$$D View this record in MEDLINE/PubMed
BookMark eNp1kU2LFDEQhoOsuLOrV4_SF8FLj5XPnpxEBnUXFrzoOVSnqzVLuntM0gv7780yMwjCUilyqOetSuW9YhfzMhNjbzlsOVj78X6atrAF08mdbeEF23DVyVYbpS7YBkCIVhiuL9lVzvcAvJPSvmKXQimjjO02jG5zU35Togbnx-YB40pNmJuJMK8pzL-aEcljbGoe0lLIl1qtZx-XXFIYwjo1QxjH4EOk5rDkUMIDnVUZp0Ok_Ok1ezlizPTmdF-zn1-__NjftHffv93uP9-1XgpdWhwUwaiERVTcGL3rrbViUH6AGsR7gVIOpLlFsJ0F02vNewkGdr4ftZfX7MOxb33rn5VycVPInmLEmZY1O645gAUNUNF3J3TtJxrcIYUJ06M7f00F3p8AzHWXMeHsQ_7H7aQVwHXl1JHzack50eh8KFjCMpeEIToO7skpV51y4I5Ouaf52_9k587PCP4C0FaV3w
CODEN JMMIAV
CitedBy_id crossref_primary_10_1007_s10096_017_3080_y
crossref_primary_10_3389_fphys_2022_881816
crossref_primary_10_1136_bmj_l4609
crossref_primary_10_33192_smj_v76i4_267058
crossref_primary_10_1080_00365521_2017_1392598
crossref_primary_10_3343_alm_2017_37_1_53
crossref_primary_10_1128_JCM_02230_15
crossref_primary_10_1007_s10096_018_3381_9
crossref_primary_10_1093_cid_cix669
crossref_primary_10_1186_s12879_016_1618_8
crossref_primary_10_1371_journal_pone_0106118
crossref_primary_10_1016_j_idc_2014_11_008
Cites_doi 10.1111/j.1651-2227.2010.01843.x
10.1136/fg.2010.001362
10.1111/1469-0691.12057
10.1258/acb.2012.011272
10.1046/j.1365-2036.2002.01196.x
10.1016/j.jhin.2013.05.006
10.1128/CMR.00016-13
10.1097/MPG.0b013e318262a718
10.1111/j.1469-0691.2009.03098.x
10.1128/JCM.02735-12
10.3109/00365521.2013.775329
10.1001/archinte.1996.00440120107012
10.1016/j.amjmed.2008.06.034
10.1080/09674845.2009.11730269
10.1038/ng.2478
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright_xml – notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1099/jmm.0.067389-0
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1473-5644
EndPage 593
ExternalDocumentID 24464697
28392015
10_1099_jmm_0_067389_0
Genre Evaluation Study
Journal Article
GroupedDBID ---
-~X
18M
2WC
4.4
53G
5GY
5RE
5RS
AAYEP
AAYXX
ABOCM
ACGFO
ACPEE
ADBBV
ADCDP
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C45
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
L7B
M5~
OBC
OBS
OEB
OFXIZ
OK1
OVD
OWW
P0W
P2P
RGM
TEORI
TR2
VVN
W8F
WOQ
YFH
YQY
.55
.GJ
08G
1KJ
3O-
5VS
AAKAS
ACBNA
ADZCM
AFFNX
AFOSN
AI.
AJKYU
CAG
COF
EX3
IQODW
NTWIH
OHT
VH1
WOW
X7M
YQJ
ZE2
ZGI
ZXP
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7X8
ID FETCH-LOGICAL-c325t-ad4e0f429aa416658b9992d4cd0d0de1b2a33de519a097906b551b30608cbf5c3
ISSN 0022-2615
1473-5644
IngestDate Thu Sep 04 15:19:24 EDT 2025
Wed Feb 19 02:31:24 EST 2025
Wed Apr 02 07:20:33 EDT 2025
Wed Oct 01 03:34:32 EDT 2025
Thu Apr 24 23:03:19 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Clostridiales
Bacteria
Feces
Clostridiaceae
Clostridium difficile
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c325t-ad4e0f429aa416658b9992d4cd0d0de1b2a33de519a097906b551b30608cbf5c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 24464697
PQID 1510090500
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1510090500
pubmed_primary_24464697
pascalfrancis_primary_28392015
crossref_citationtrail_10_1099_jmm_0_067389_0
crossref_primary_10_1099_jmm_0_067389_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-04-01
PublicationDateYYYYMMDD 2014-04-01
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Reading
PublicationPlace_xml – name: Reading
– name: England
PublicationTitle Journal of medical microbiology
PublicationTitleAlternate J Med Microbiol
PublicationYear 2014
Publisher Society for General Microbiology
Publisher_xml – name: Society for General Microbiology
References r2
r3
r4
r5
r7
r9
(r8) 2006
r10
r12
r11
r14
r13
Lamb (r3a) 2011; 2
r15
Wren (r16) 2009; 66
(r6) 2012
r1
References_xml – ident: r13
  doi: 10.1111/j.1651-2227.2010.01843.x
– volume-title: Updated guidance on the diagnosis and reporting of Clostridium difficile
  year: 2012
  ident: r6
– volume: 2
  start-page: 13
  year: 2011
  ident: r3a
  article-title: Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
  publication-title: Frontline Gastroenterol
  doi: 10.1136/fg.2010.001362
– ident: r15
  doi: 10.1111/1469-0691.12057
– ident: r14
  doi: 10.1258/acb.2012.011272
– ident: r11
  doi: 10.1046/j.1365-2036.2002.01196.x
– volume-title: Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust
  year: 2006
  ident: r8
– ident: r1
  doi: 10.1016/j.jhin.2013.05.006
– ident: r3
  doi: 10.1128/CMR.00016-13
– ident: r4
  doi: 10.1097/MPG.0b013e318262a718
– ident: r5
  doi: 10.1111/j.1469-0691.2009.03098.x
– ident: r9
  doi: 10.1128/JCM.02735-12
– ident: r10
  doi: 10.3109/00365521.2013.775329
– ident: r2
  doi: 10.1001/archinte.1996.00440120107012
– ident: r12
  doi: 10.1016/j.amjmed.2008.06.034
– volume: 66
  start-page: 175
  year: 2009
  ident: r16
  article-title: Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm
  publication-title: Br J Biomed Sci
  doi: 10.1080/09674845.2009.11730269
– ident: r7
  doi: 10.1038/ng.2478
SSID ssj0017339
Score 2.1724167
Snippet Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive...
Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 590
SubjectTerms Adult
Aged
Aged, 80 and over
Bacterial Toxins - analysis
Bacteriology
Biological and medical sciences
Clostridium difficile - isolation & purification
Clostridium Infections - diagnosis
Diagnostic Tests, Routine - methods
Diarrhea - diagnosis
Enzyme-Linked Immunosorbent Assay - methods
Feces - chemistry
Female
Fundamental and applied biological sciences. Psychology
Humans
Infectious diseases
Leukocyte L1 Antigen Complex - analysis
Male
Medical sciences
Microbiology
Middle Aged
Miscellaneous
ROC Curve
Sensitivity and Specificity
Young Adult
Title Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples?
URI https://www.ncbi.nlm.nih.gov/pubmed/24464697
https://www.proquest.com/docview/1510090500
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1473-5644
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0017339
  issn: 0022-2615
  databaseCode: DIK
  dateStart: 19680101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1473-5644
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0017339
  issn: 0022-2615
  databaseCode: GX1
  dateStart: 19680101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEAgJIRiXlctkJBAPVTo3cZz5CaGxaYN1INFKfYtsx9UimrQj6cN45JdzbOdW2KSBIkWVZbtVv88n34mPz0Hozb7mifKp9ljEBTgosKQkrG8vmks_EVIl3B4fG5-x4yn9NAtnvd6vTtTSupRD9fPKcyX_gyq0Aa7mlOw_INtMCg3wGfCFOyAM9xthfFIY3Wh3AC4HJm23zQCS2dd-NkJSaJv_QyyqdAypjWs8WCxNtY4kXWe2QEqqwDQMXPiWSQLuRhXCJA4u_oj86wjYrNrjydI2mVNr40HKnlf8-QZ8yDv7T-dpfeThMyjdzlmI5XLlGDROvzeEs1OYMCLdfUMx6ga2OKNKo8ALmcvzONRXtFWWuDJ1jnFfywHtWNbQVRX9y-KDwjUWP8uGZGiK7pgIsPbZVu_nn32Jj6anp_HkcDaBJbW68EzdMbM__zb46IhxC9324clgy3_MmjChURTYanTN720Sf_K9zS_dEDb3V6IABOauOMr13otVMZOH6EGFHv7guPQI9XS-je64gqSX2-juuAq1eIz0SYEtuTCQC1ty4TTHDbmwownukst06JALN-TCNbnqURW53j9B06PDycGxV9Xk8FTgh6UnEqrJHESMECDlQb5K8DD8hKqEwKVH0hdBkGjwCwThESdMgiSX4JeSfSXnoQqeoq18mesdhIMIrhEPtWJzyojgzJdMcUETIpJIsj7y6j80VlXCelM3ZRG7wAkeAwAxiR0AMemjd03_lUvVcm3P3Q18mu6-cRdAIPfR6xqwGMyt2UMTuV6uixgEMnglJCQwyTOHZDuaUkYZj57fYPQLdK9dKi_RVvljrV-BvC3lruXfbwXCqOU
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+there+any+value+in+measuring+faecal+calprotectin+in+Clostridium+difficile+positive+faecal+samples%3F&rft.jtitle=Journal+of+medical+microbiology&rft.au=Whitehead%2C+Simon+J&rft.au=Shipman%2C+Kate+E&rft.au=Cooper%2C+Mike&rft.au=d%2C+Clare&rft.date=2014-04-01&rft.issn=1473-5644&rft.eissn=1473-5644&rft.volume=63&rft.issue=Pt+4&rft.spage=590&rft_id=info:doi/10.1099%2Fjmm.0.067389-0&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2615&client=summon